STT
59
11
XRX
59
11
SYY
41
-2
EQT
50
3
FRT
36
2
AON
28
2
IVZ
48
6
MOS
38
2
HP
34
-10
MCHP
36
3
HUM
29
4
BF.B
33
-3
HAL
30
-10
NWS
75
4
FDX
33
-11
CHRW
51
-2
UNM
70
3
MSI
54
2
MSFT
53
-2
NRG
37
5
STT
59
11
XRX
59
11
SYY
41
-2
EQT
50
3
FRT
36
2
AON
28
2
IVZ
48
6
MOS
38
2
HP
34
-10
MCHP
36
3
HUM
29
4
BF.B
33
-3
HAL
30
-10
NWS
75
4
FDX
33
-11
CHRW
51
-2
UNM
70
3
MSI
54
2
MSFT
53
-2
NRG
37
5
Financhill
Back

Ligand Pharmaceuticals Vs. Nukkleus Industry Stock Comparison

Sell
48

LGND
Ligand Pharmaceuticals

Last Price:
$113.45
Seasonality Move:
9.17%
Sell
46

NUKK
Nukkleus

Last Price:
$36.44
Seasonality Move:
-19.41%
Sell
48
Ligand Pharmaceuticals (LGND) is a Sell

Is Ligand Pharmaceuticals a Buy, Sell or Hold?

  • The current Ligand Pharmaceuticals [LGND] share price is $113.80. The Score for LGND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • LGND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

  • The current Nukkleus [NUKK] share price is $41.76. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LGND Stock Price Chart

What is Ligand Pharmaceuticals's stock price today?

  • The Ligand Pharmaceuticals share price today is $113.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LGND is experiencing selling pressure, which indicates risk of future bearish movement.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

  • The Nukkleus share price today is $41.76
    The current trend is moderately bullish and NUKK is experiencing selling pressure, which indicates risk of future bearish movement.

LGND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 45.5 Sell
Chaikin Money Flow: -76253 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (114.14 - 122.4) Sell
Bollinger Bands (100): (100.52 - 116.88) Buy

NUKK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.75 Buy
Relative Strength Index (14 RSI): 78.03 Buy
Chaikin Money Flow: -1645260 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-7.27 - 25.57) Buy
Bollinger Bands (100): (-4.7 - 12.76) Buy

LGND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.23 Sell
20-day SMA: 119.3 Sell
50-day SMA: 115.23 Sell
200-day SMA: 95.57 Buy
8-day EMA: 116.1 Sell
20-day EMA: 117.33 Sell
50-day EMA: 114.73 Sell
200-day EMA: 99.09 Buy

NUKK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.1 Buy
20-day SMA: 11 Buy
50-day SMA: 5.78 Buy
200-day SMA: 4.96 Buy
8-day EMA: 29.9 Buy
20-day EMA: 16.84 Buy
50-day EMA: 8.81 Buy
200-day EMA: 12.07 Buy

Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and an increase next year of $0.48 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ligand Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):